In thisarticle, we aimed to prepare a recommendation guide including the thromboprophylaxis and management of patients diagnosed with DVTduring the COVID-19 outbreak.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Since the first case of coronavirus disease 2019 (COVID-19) was reported at the end of 2019, this outbreak has spread to more than amillion people around the world and become a pandemic.
📊
Key Findings & Data:The group most affected by the outbreak with the highest mortality rate is elderlypeople with known vascular diseases or a high risk of developing vascular pathologies.
💡
Conclusion & Impact:In thisarticle, we aimed to prepare a recommendation guide including the thromboprophylaxis and management of patients diagnosed with DVTduring the COVID-19 outbreak.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Özet
Since the first case of coronavirus disease 2019 (COVID-19) was reported at the end of 2019, this outbreak has spread to more than amillion people around the world and become a pandemic. The group most affected by the outbreak with the highest mortality rate is elderlypeople with known vascular diseases or a high risk of developing vascular pathologies. It is evident that in this group of patients, there isa high risk of deep vein thrombosis (DVT) occurrence. In this current extraordinary era, management will be more challenging. In thisarticle, we aimed to prepare a recommendation guide including the thromboprophylaxis and management of patients diagnosed with DVTduring the COVID-19 outbreak.
🔖
Cite This Article
GÜNERTEM, E., AKAY, H. T., ALİYEV, A., BEYAZPINAR, D. S., ERDİL, N., ERER, D., BAYRAK, S., ÇALKAVUR, T., BOZKURT, K. (2020). Treatment and prophylaxis strategies for deep vein thrombosis during COVID-19 outbreak. Turkish journal of vascular surgery, Cilt: 29 - Sayı: 3, 203–207. https://ajindex.com/articles/375741
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. [Epub ahead of print] 2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020
Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. [cited 2020 Mar 21]. Available at: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/technical-guidance/namingthe- coronavirus-disease-(covid-2019)-and-the-virusthatcauses- it. [Accessed: Mar 23, 2020]. 4. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003
I9-16. 5. White RH. The epidemiology of venous thromboembolism. Circulation 2003
I4-8. 6. Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016
Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012
Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, et al. Post-thrombotic syndrome after catheterdirected thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 2016
e64-71. 10. Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, et al. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation 2019
Notten P, Ten Cate-Hoek AJ, Arnoldussen CWKP, Strijkers RHW, de Smet AAEA, Tick LW, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol 2020
e40-e9. 12. Bozkur K. Periferik Arter ve Ven Hastalıkları-Ulusal Tedavi Kılavuzu. In: Bozkurt AK, editör. Venöz Tromboemboli Tedavisi. 1. Baskı. İstanbul: Bayçınar Tıbbi Yayıncılık
s. 123-41. 13. Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020. pii: /j/cclm.ahead-of-print/cclm-2020